Chronic Pain Management, Mobile Technology and Clean Energy in This Week's Small-Cap Specialists Research Reports

Chronic Pain Management, Mobile Technology and Clean Energy in This Week's 
Small-Cap Specialists Research Reports 
NEW YORK, NY -- (Marketwired) -- 05/03/13 --  Competitive
Technologies, (OTCQX: CTTC), distributor of a non-narcotic and
non-invasive medical device for the treatment of chronic pain, may be
entering a "Perfect Storm" of media exposure and corporate
developments in the next few weeks. The American Society of Clinical
Oncology (ASCO) has an upcoming Annual meeting where promising
technologies and biopharmaceutical advances are presented to the
cancer medical community. These presentations can have a dramatic
effect on the share prices of publicly-held companies to the degree
that the SEC has asked ASCO to enforce a news embargo until May 15,
when all presentations on the schedule for the ASCO meeting are
posted on the ASCO website. CTTC's Calmare medical device has been in
clinical studies with the Mayo Clinic, University of Wisconsin and
Virginia Commonwealth University. And all three institutions are
expected to release their patient data very soon. There is no
guarantee that Calmare will be the subject of a presentation at the
ASCO meeting, but there is speculation that at least one of the three
institutions will be highlighting Calmare and its effects on chronic
pain patients suffering from neuropathic pain. With only 16.4 Million
shares outstanding, a recent price of $0.235 and considering the
details -- including TV news videos -- in the CTTC Research Report
available here, CTTC is one to watch for potential gains in May (CTTC
websites: http://www.competitivetech.net/ and www.calmarett.com).
Much more on CTTC in the CTTC Research Report available here:
http://bit.ly/OTCBBRESEARCH 
GDT Tek, Inc. (PINKSHEETS: GDTK) is a Florida-based publicly traded
company (PINKSHEETS: GDTK) focused on renewable and sustainable
energy technologies. The company has licensed patented waste heat to
electric power generation technology and is driving its adoption by
power plants, landfills and other waste-heat generating industries.
GDT Tek's waste heat to electricity systems are powerful enough to
serve as a primary energy source, highly efficient, immediately
cash-flow positive when installed under a Power
 Purchase Agreement
and are scalable with system sizes from 150 KW/Hr. to 5000 KW/Hr.
currently available. The GDT Tek system has been proven through a
long-term five year installation at a San Jose, California-area
landfill. Waste heat captured from landfill-generated methane gas
generator engine exhaust and radiator jacket coolant systems is used
by the GDT Tek system to generate electricity which is then sold to
the grid. GDT Tek's heat to power conversion technology solution is
proven to be the most reliable, versatile, efficient, lowest
emissions, and overall cost-effective solution available in today's
changing world market. Recent company updates and more can be found
in our full research report here: http://bit.ly/OTCBBRESEARCH 
Medizone International Inc. (OTCQB: MZEI) has enjoyed a recent
upswing in the PPS and increased trading. MZEI announced on April
11th, 2013 that an agreement has been reached with Canada's largest
distributor of sanitary products. Management has recently shared
their assessment of the current interest in their stock. To view the
full assessment and research report click here:
http://bit.ly/OTCBBRESEARCH 
Hii Technologies, Inc. (OTCQB: HIIT) has investors very excited over
recent revenue announcements and future potential earnings. Since the
press release issued on April 10th, 2013 stating that the revenues
were up over 300% for the quarter ending March 31st, 2013 from the
same quarter in 2012, the PPS has risen nearly 39%. To learn more
about future potential earnings and Q and A session with the Mathew
Flemming, CEO of HIIT, follow the link provided:
http://bit.ly/OTCBBRESEARCH 
Receive mobile alerts and a free VIP membership: text "OtcbbAlerts"
to 25827 
Disclaimer:  Information, opinions and analysis contained herein are
based on sources believed to be reliable, but no representation,
expressed or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only, and
is neither a solicitation to buy nor an offer to sell securities.
Certain information included herein is forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, but not limited to, statements concerning manufacturing,
marketing, growth, and expansion. Such forward-looking information
involves important risks and uncertainties that could affect actual
results and cause them to differ materially from expectations
expressed herein. We have NOT been compensated for the mention of any
of the companies in this press release. 
Contact:
Susan Laidler
Senior Editor
Editor@OtcBBJournal.com 
 
 
Press spacebar to pause and continue. Press esc to stop.